Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

19 further concessionary prices announced for September

The Department of Health and Social Care and the National Assembly for Wales have agreed concessionary prices for the following items for September 2018 prescriptions.

The first set of eight concessionary prices for the month were announced last week (September 18).

Drug
Strength
Form
Price
Amisulpride
200mg
tablets (60)
£13.58
Brimonidine
0.2%
eye drops (5ml)
£3.64
Lamotrigine
25mg
tablets (56)
£5.15
Lamotrigine
50mg
tablets (56)
£8.00
Lamotrigine
100mg
tablets (56)
£14.75
Lamotrigine
200mg
tablets (56)
£21.50
Latanoprost
50mcg/ml
eye drops (2.5ml)
£9.75
Mometasone
0.1%
cream (100g)
£7.90
Mometasone
0.1%
ointment (30g)
£2.88
Mometasone
0.1%
ointment (100g)
£7.50
Nicorandil
10mg
tablets (60)
£3.50
Orlistat
120mg
capsules (84)
£23.95
Ramipril
2.5mg
tablets (28)
£4.00
Ramipril
5mg
tablets (28)
£4.50
Ramipril
10mg
tablets (28)
£3.20
Sodium valproate
200mg
gastro-resistant tablets (100)
£6.29
Sumatriptan
50mg
tablets (6)
£3.50
Tadalafil
5mg
tablets (28)
£29.00
Topiramate
50mg
tablets (60)
£9.46

Which of these medicines do you dispense most often?

Related Content

Topics



Pharmacist Managers - Recruiting Now !
East London, Essex and Luton
£40,000 - £50,000 per year

Apply Now
UsernamePublicRestriction

Register

CD005542

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel